On the public citation graph
Chronic Hepatitis B Patients Under Nucleos(t)ide Analogues Treatment with Omicron BA.5 Infection: A Retrospective Study in South China
0 signed · 30 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/hep.31267openalex-extracted
Comparative Effectiveness of Entecavir Versus Tenofovir for Preventing Hepatocellular Carcinoma in Patients with Chronic Hepatitis B: A Systematic Review and Meta‐Analysis
inferredcites →https://doi.org/10.1002/jmv.26201openalex-extracted
A case series of COVID‐19 patients with chronic hepatitis B virus infection
inferredcites →https://doi.org/10.1002/jmv.28695openalex-extracted
Humoral responses after primary and booster SARS‐CoV‐2 inactivated vaccination in patients with chronic hepatitis B virus infection: A longitudinal observational study
inferredcites →https://doi.org/10.1002/rmv.2391openalex-extracted
Update on the omicron sub‐variants BA.4 and BA.5
inferredcites →https://doi.org/10.1007/s10620-022-07687-2openalex-extracted
Effects of Hepatitis B Virus Infection on Patients with COVID-19: A Meta-Analysis
inferredcites →https://doi.org/10.1007/s11684-021-0854-5openalex-extracted
Clinical characteristics and risk factors of COVID-19 patients with chronic hepatitis B: a multi-center retrospective cohort study
inferredcites →https://doi.org/10.1007/s12072-022-10306-xopenalex-extracted
Management of hepatitis B virus reactivation due to treatment of COVID-19
inferredcites →https://doi.org/10.1007/s40121-022-00638-4openalex-extracted
Patients with COVID-19 and HBV Coinfection are at Risk of Poor Prognosis
inferredcites →https://doi.org/10.1016/j.antiviral.2020.104857openalex-extracted
A library of nucleotide analogues terminate RNA synthesis catalyzed by polymerases of coronaviruses that cause SARS and COVID-19
inferredcites →https://doi.org/10.1016/j.cmi.2021.11.002openalex-extracted
Female gender is associated with long COVID syndrome: a prospective cohort study
inferredcites →https://doi.org/10.1016/j.lfs.2020.117592openalex-extracted
Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study
inferredcites →https://doi.org/10.1016/s2468-1253(20)30057-1openalex-extracted
Liver injury in COVID-19: management and challenges
inferredcites →https://doi.org/10.1016/s2666-5247(21)00266-4openalex-extracted
WHO International Standard for evaluation of the antibody response to COVID-19 vaccines: call for urgent action by the scientific community
inferredcites →https://doi.org/10.1038/s41392-022-01009-8openalex-extracted
Omicron: increased transmissibility and decreased pathogenicity
inferredcites →https://doi.org/10.1038/s41575-018-0041-6openalex-extracted
The hepatitis B epidemic and the urgent need for cure preparedness
inferredcites →https://doi.org/10.1056/nejme2002387openalex-extracted
Covid-19 — Navigating the Uncharted
inferredcites →https://doi.org/10.1111/jvh.13362openalex-extracted
Clinical characteristics in patients with SARS‐CoV‐2/HBV co‐infection
inferredcites →https://doi.org/10.1111/liv.14774openalex-extracted
Clinical characteristics of COVID‐19 patients with hepatitis B virus infection — a retrospective study
inferredcites →https://doi.org/10.1128/aac.00138-06openalex-extracted
Intracellular Metabolism and In Vitro Activity of Tenofovir against Hepatitis B Virus
inferredcites →https://doi.org/10.1186/s12992-022-00804-wopenalex-extracted
COVID-19, sex, and gender in China: a scoping review
inferredcites →https://doi.org/10.2471/blt.18.219469openalex-extracted
Countdown to 2030: eliminating hepatitis B disease, China
inferredcites →https://doi.org/10.3138/canlivj-2020-0029openalex-extracted
HBV coinfection and in-hospital outcomes for COVID-19: a systematic review and meta-analysis
inferredcites →https://doi.org/10.3389/fimmu.2021.733364openalex-extracted
Interferon and Hepatitis B: Current and Future Perspectives
inferredcites →https://doi.org/10.3389/fimmu.2022.1104329openalex-extracted
Serum IL-5 levels predict HBsAg seroclearance in patients treated with Nucleos(t)ide analogues combined with pegylated interferon
inferredcites →https://doi.org/10.3389/fmicb.2023.1185492openalex-extracted
Tenofovir alafenamide versus entecavir for treating hepatitis B virus-related acute-on-chronic liver failure: real-world study
inferredcites →https://doi.org/10.3390/pathogens11070816openalex-extracted
COVID-19 as Another Trigger for HBV Reactivation: Clinical Case and Review of Literature
inferredcites →https://doi.org/10.3748/wjg.v11.i14.2061openalex-extracted
Clinical analysis of the risk factors for recurrence of HCC and its relationship with HBV
inferredcites →https://doi.org/10.3748/wjg.v27.i9.782openalex-extracted
Interaction between hepatitis B virus and SARS-CoV-2 infections
inferredcites →https://doi.org/10.4110/in.2015.15.4.191openalex-extracted
Immune-mediated Liver Injury in Hepatitis B Virus Infection
inferredcites →https://doi.org/10.7759/cureus.8645openalex-extracted
COVID-19 Induced Hepatitis B Virus Reactivation: A Novel Case From the United Arab Emirates
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.